Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Reexamination Certificate
2006-03-22
2008-03-25
Monshipouri, Maryam (Department: 1656)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
C530S363000, C514S002600
Reexamination Certificate
active
07348312
ABSTRACT:
A composition comprising an albumin-based colloid and its use in treating hypovolemic conditions such as capillary leak syndrome and shock are disclosed.
REFERENCES:
patent: 2727027 (1955-12-01), Monson et al.
patent: 4101380 (1978-07-01), Rubinstein et al.
patent: 4179337 (1979-12-01), Davis et al.
patent: 5324844 (1994-06-01), Zalipsky
patent: 5583114 (1996-12-01), Barrows et al.
patent: 5650234 (1997-07-01), Dolence et al.
patent: 5704358 (1998-01-01), Zikria
patent: 5714511 (1998-02-01), Saavedra et al.
patent: 5733563 (1998-03-01), Fortier
patent: 5756481 (1998-05-01), Arnal et al.
patent: 5952009 (1999-09-01), Neurath et al.
patent: 6063764 (2000-05-01), Creasey et al.
patent: 6129912 (2000-10-01), Hortin et al.
patent: 6344197 (2002-02-01), Fisher et al.
Wu Lin, Martin C. Garnett, Etienne Schacht, Stanley S. Davis, Lisbeth Illum,Preparation and in vitro characterization of HAS-mPEG nanoparticles, International Journal of Pharmaceutics, 189 (1999), pp. 161-170.
Angus, D.C., Wax, R.S.,Epidemiology of Sepsis-An Update, Critical Care Medicine.29(7)(2001) S109-S116.
Baue, A.E. Durham, R. Faist, E.,Systemic Inflammatory Response Syndrome(SIRS)Multiple Organ Dysfunction Syndrome(MODS),Multiple Organ Failure(MOF)Are We Winning The Battle?, Shock,10(2)(1998) 79-89.
Roberts, J.S., Bratton, S.L.,Colloid volume expanders: problems, pitfalls and possibilities, Drugs. 55(5)(1998)621-630.
Berger, A.,Why albumin may not work(editor's commentary). BMJ (1998) 317:240.
Doweiko, J.P., and Nompleggi, D.J.,Interactions of Albumin and Medications, J. Parenter. Enteral. Nutr. 15,(1991)212-214.
Emerson, T.E.,Unique features of albumin; a brief review, Crit Care Med. 17(7)(1989)690-694.
Margarson, M.P., Soni. N.,Serum Albumin: touchstone or totem? Anaesthesia, 53, (1998) 789-803.
McClelland,Human albumin administration in critically ill patients, BMJ. 317 (1998)882-886.
Wilkes, M., and Navickis, R.J.,Patient survival after human albumin administration, Ann Intern Med. 135 (2001)149-164.
Cochrane Injuries Group Albumin Reviewers,Human albumin administration in critically ill patients: systematic review of randomized controlled trials, BMJ. 317(1998)235-40.
Delgado, C. Francis, G.E. and Fisher, D.,The uses of properties of PEG-linked proteins. Critical Reviews in Therapeutic Drug Carrier Systems 9(3,4)(1992)249-304.
Abuchowski, A., van Es, T., Palozuk, N.C., and Davis, F.,Alteration of immunological properties of bovine serum albumin by covalent attachment of polyethylene glycol, J. Biol Chem. 252(11)(1977)3578-3581.
Kozlowski A; Charles SA; Harris JM,Development of pegylated interferons for the treatmnet of chronic hepatitis C, BioDrugs 15 (2001)419-29.
Conover, C., Malatesta, P., Lejuene, Chang, C.L., and Shorr, R.G.L.,The effects of hemodilution with polyethylene glycol bovine hemoglobin(Peg-hb)in a conscious porcine model, J. Inves Med. 44(5)(1996) 238-246.
Conover, C.D., Lejuene, L, Shum, K., Gilbert, C., and Shorr, R.G.,Physiological effect of polyethyelen glycol conjugation of stroma-free bovine hemoglobin in the conscious dog after partial exchange transfusion, Artif Organs. 21(5)(1997) 369-78.
Conover, C.D., Linberg, R., Lejuene, L., Nagy, M., and Shum, K.L.,PEG-hemoglobin as a resuscitation solution in the treatment of hypovolemic shock in the anesthetized rat, Artif. Organs. 23(12)(1999) 1088-1098.
Yeh, T., Parmar, J.M., Rebeyka, I.M., Lofland, G.K., Allen, E.L., Dignan, R.J., et al.,Limiting edema in neonatal cardiopulmonary bypass with narrow-range molecular weight hydroxyethyl starch, J. Thorac Cardiovasc Surg. 104 (1992)659-65.
Axon, R.N., Baird, J.S., Lang, J.D., Brix, A.E., Nielson, V.G.,Pentalyte Decreases Lung Injury After Aortic Occlusion-Reperfusion, Am J. Reespir.CritCare Med. 157(1998) 1982-1990.
Henekak, M.T., Loschmann, P.A., Osswald, H.,Polymerized Hemoglobin Restores Cadiovascular and Kidney Function in Endotoxin-induced Shock in the Rat, J.Clin.Invest. 99(1997)47-54.
Zoellner, H., Hoffler, M., Beckmann, R., Hufnagl, Vanyek, E., Blekel E., et al.,Serum albumin is a specific inhibitor of apoptosis in human endothelial cells, J Cell Science, 109(1996) 2571-2580.
Cantin, A.M., Paquette, B.K. Richter, M., and Larivee, P.,Albumin-mediated regulation of cellular glutathione and nuclear factor Kappa B activation, Am J Respir Crit Care Med, 162 (2000) 1539-1546.
Assaly, R., Olson, D., Hammersely, J., Fan, P.S., Liu J., Shapiro J., Kahaleh, B.,Initial Evidence of Endothelial Cell Apoptosis as a Mechanism of Systemic Capillary Leak Syndrome, Chest:120(2001)1301-1308.
Quinlan, G.J., Margarson, M.P., Mumby, S., Evans, T.W., Gutteridge, J.M.C.,Administration of albumin to patients with sepsis syndrome: a possible benefical role in a plasma thiol repletion, Clin.Sci. 95 (1998) 459-465.
Filep, J.G., Delalandre, A., Beauchamp, M., Dual role for nitric oxide in the regulation of plasma volume and albumin escape during endotoxin shock in conscious rats, Circ. Res., 81 (1997) 840-847.
Tanford, C.,Physical Chemistry of Macromolecules, John Wiley & Sons, (1961) p. 217.
Vandegriff, K.D., McCarthy, M., Rohlfs, R.J., and Winslow, R.M.Colloid osmotic properties of modified hemoglobins: chemically cross-linked versus polyethylene glycol surface-conjugated, Biophys. Chem 69 (1997) 23-30.
Laemmli, U.K.,Cleavage of structural proteins during the assembly of the head of bacteriophageT4, Nature, 227 (1970) 6980-6985.
Johnson, D.E.,Applied Multivariate Methods for Data Analysis, Duxbury Press, (1998) p. 319-321.
Bullock, Jr., Characterization of Polyethelene glycol-Modified Superoxide Dismutase:Comparison of Capillary Electrophoresis and Marix-Assisted Laser Desorption/Ionization Mass Spectometry,Anal.Chem. 68(1996) 3258-3264.
Veronese, F.M.,Peptide and protein PEGylation: a review of problems and solutions, Biomaterials 22 (2001)405-417.
Nathan, C.,Inducible Nitric Oxide Synthase: What Difference Does It Make? J.Clin.Invest., 100(10)(1997) 2417-2423.
Hubbard, J.D., Janssen, H.F.,Increased microvascular permeability for canine endotoxic shock: protective effects of ibuprofen, Circ Shock 26 (1988) 169-183.
Taylor, AE, Granger DN, Exchange of macromolecules across the microcirculation. Handbook of Physiology, The Cardiovascular System IV, Am Physiol Soc, 4(1)11 (1984)467-520.
Hershey, S.G. and Altura, Burton M.; Effect of Pretreatment with Aggregate Albumin on Reticuloendothelial System Activity and Survival After Experimental Shock; Proceedings of the Society for Experimental Biology and Medicine; Aug.-Sep. 1966—vol. 122, No. 4.
Assaly Ragheb
Dignam John D.
Shapiro Joseph I.
Emch, Schaffer, Schaub & Porcello & Co., L.P.A.
Medical College of Ohio
Monshipouri Maryam
Tsay Marsha
LandOfFree
Albumin-based colloid composition and method of use in... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Albumin-based colloid composition and method of use in..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Albumin-based colloid composition and method of use in... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3974663